Study finds aspirin reduces risk of death in hospitalized Covid-19 patients

(Image for Representation)

WASHINGTON: A new study led by researchers at the University of Maryland School of Medicine (UMSOM), has found that hospitalized Covid-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who did not take aspirin.